G. Walmsley Graham, Director at Akero Therapeutics, Inc. (AKRO), bought 55,000 shares at $42.69 ($2.4M) on 2023-07-28, disclosed to the SEC on 2023-08-01.
Open-market purchase of $2.4M AKRO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.69 | 30,000 | $1.3M | 54.2% |
| 2 | $43.26 | 25,000 | $1.1M | 45.8% |
| Total | $42.95 avg | 55,000 | $2.4M | 100% |
| Filing → |
| OLMA | SELL | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-17 | $4.7M | — | Filing → |